As of 2024-12-11, the Fair Value of Basilea Pharmaceutica AG (BSLN.SW) is -1.34 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 41.10 CHF, the upside of Basilea Pharmaceutica AG is -103.27%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -22.42 | -14.72 | -6.83 | 12.15 | 10.45 | -4.28 |
| YoY growth | 28.48% | 34.34% | 53.60% | 277.82% | -13.96% | 76.06% |
| Market Cap (mil) | 498.18 |
| P/E | |
| Forward P/E | 53.20x |
| EPS | -0.05 |
| Avg earnings growth rate | 76.06% |
| TTM earnings | -0.65 |